Hainaut P - Search Results

1

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

Olivier M, Langerød A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bièche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Børresen-Dale AL. Olivier M, et al. Among authors: hainaut p. Clin Cancer Res. 2006 Feb 15;12(4):1157-67. doi: 10.1158/1078-0432.CCR-05-1029. Clin Cancer Res. 2006. PMID: 16489069

2

Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas.

Esteve A, Martel-Planche G, Sylla BS, Hollstein M, Hainaut P, Montesano R. Esteve A, et al. Among authors: hainaut p. Int J Cancer. 1996 May 3;66(3):301-4. doi: 10.1002/(SICI)1097-0215(19960503)66:3<301::AID-IJC5>3.0.CO;2-2. Int J Cancer. 1996. PMID: 8621247

3

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.

Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC, Montesano R. Hainaut P, et al. Nucleic Acids Res. 1997 Jan 1;25(1):151-7. doi: 10.1093/nar/25.1.151. Nucleic Acids Res. 1997. PMID: 9016527 Free PMC article.

4

Inactivation of the p53 protein in cell lines derived from human esophageal cancers.

Barnas C, Martel-Planche G, Furukawa Y, Hollstein M, Montesano R, Hainaut P. Barnas C, et al. Among authors: hainaut p. Int J Cancer. 1997 Mar 28;71(1):79-87. doi: 10.1002/(sici)1097-0215(19970328)71:1<79::aid-ijc14>3.0.co;2-4. Int J Cancer. 1997. PMID: 9096669

5

Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein.

Calmels S, Hainaut P, Ohshima H. Calmels S, et al. Among authors: hainaut p. Cancer Res. 1997 Aug 15;57(16):3365-9. Cancer Res. 1997. PMID: 9269997

6

TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.

Børresen-Dale AL, Lothe RA, Meling GI, Hainaut P, Rognum TO, Skovlund E. Børresen-Dale AL, et al. Among authors: hainaut p. Clin Cancer Res. 1998 Jan;4(1):203-10. Clin Cancer Res. 1998. PMID: 9516972

7

Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.

Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H. Gratas C, et al. Among authors: hainaut p. Cancer Res. 1998 May 15;58(10):2057-62. Cancer Res. 1998. PMID: 9605741

8

Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines.

Sørlie T, Martel-Planche G, Hainaut P, Lewalter J, Holm R, Børresen-Dale AL, Montesano R. Sørlie T, et al. Among authors: hainaut p. Br J Cancer. 1998 May;77(10):1573-9. doi: 10.1038/bjc.1998.259. Br J Cancer. 1998. PMID: 9635831 Free PMC article.

9

p53 as a sensor of carcinogenic exposures: mechanisms of p53 protein induction and lessons from p53 gene mutations.

Hainaut P, Vähäkangas K. Hainaut P, et al. Pathol Biol (Paris). 1997 Dec;45(10):833-44. Pathol Biol (Paris). 1997. PMID: 9769947 Review.

10

Sources of bias in the detection and reporting of p53 mutations in human cancer: analysis of the IARC p53 mutation database.

Hernandez-Boussard T, Montesano R, Hainaut P. Hernandez-Boussard T, et al. Among authors: hainaut p. Genet Anal. 1999 Feb;14(5-6):229-33. doi: 10.1016/s1050-3862(98)00030-8. Genet Anal. 1999. PMID: 10084119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters